Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells.
Occhi G, Losa M, Albiger N, Trivellin G, Regazzo D, Scanarini M, Monteserin-Garcia JL, Fröhlich B, Ferasin S, Terreni MR, Fassina A, Vitiello L, Stalla G, Mantero F, Scaroni C. Occhi G, et al. Among authors: scanarini m. J Neuroendocrinol. 2011 Jul;23(7):641-9. doi: 10.1111/j.1365-2826.2011.02155.x. J Neuroendocrinol. 2011. PMID: 21554434
Predicting late recurrence in surgically treated patients with Cushing's disease.
Barbot M, Albiger N, Koutroumpi S, Ceccato F, Frigo AC, Manara R, Fassina A, Gardiman MP, Scanarini M, Mantero F, Scaroni C. Barbot M, et al. Among authors: scanarini m. Clin Endocrinol (Oxf). 2013 Sep;79(3):394-401. doi: 10.1111/cen.12133. Epub 2013 May 6. Clin Endocrinol (Oxf). 2013. PMID: 23278711
Activation of the dopamine receptor type-2 (DRD2) promoter by 9-cis retinoic acid in a cellular model of Cushing's disease mediates the inhibition of cell proliferation and ACTH secretion without a complete corticotroph-to-melanotroph transdifferentiation.
Occhi G, Regazzo D, Albiger NM, Ceccato F, Ferasin S, Scanarini M, Denaro L, Cosma C, Plebani M, Cassarino MF, Mantovani G, Stalla GK, Pecori Giraldi F, Paez-Pareda M, Scaroni C. Occhi G, et al. Among authors: scanarini m. Endocrinology. 2014 Sep;155(9):3538-49. doi: 10.1210/en.2013-1820. Epub 2014 Jun 13. Endocrinology. 2014. PMID: 24926820
Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
Benedini S, Dalle Carbonare L, Albiger N, Scanarini M, Bilora F, Petrobelli F, Giannini S, Mantero F, Scaroni C. Benedini S, et al. Among authors: scanarini m. Horm Metab Res. 2006 Jan;38(1):16-21. doi: 10.1055/s-2006-924970. Horm Metab Res. 2006. PMID: 16477535 Clinical Trial.
Increased rate of intracranial saccular aneurysms in acromegaly: an MR angiography study and review of the literature.
Manara R, Maffei P, Citton V, Rizzati S, Bommarito G, Ermani M, Albano I, Della Puppa A, Carollo C, Pavesi G, Scanarini M, Ceccato F, Sicolo N, Mantero F, Scaroni C, Martini C. Manara R, et al. Among authors: scanarini m. J Clin Endocrinol Metab. 2011 May;96(5):1292-300. doi: 10.1210/jc.2010-2721. Epub 2011 Feb 9. J Clin Endocrinol Metab. 2011. PMID: 21307138
79 results